Figure 3.
Neutrophil recruitment and maturation are impaired in Gsdmd−/− mice with focal TMA. (A) Representative gating of flow cytometric analysis for the quantification of neutrophils (CD45+ CD11b+ Ly6G+) and monocytes (CD45+ CD11b+ Ly6C+) in blood and kidney from WT and knockout (Gsdmd−/−) mice with focal TMA (24 hours). (B-C) Percentage of neutrophils among CD45+ cells (B) and their absolute number (C) in the blood from healthy mice (n = 6) and focal TMA mice (WT: n = 8, Gsdmd−/−: n = 8). (D-E) Percentage of neutrophils among CD45+ cells (D) and their absolute number (E) in sham (n = 4) and TMA kidneys from WT (n = 12) and Gsdmd−/− (n = 11) mice. (F) Representative gating of flow cytometric analysis for the quantification of mature (CD45+ CD11b+ Ly6G+ CD101+) and immature (CD45+ CD11b+ Ly6G+ CD101−) neutrophils in the bone marrow, spleen, and blood from WT and Gsdmd−/− mice with focal TMA. (G-I) Percentage of mature neutrophils among CD45+ CD11b+ Ly6G+ neutrophils in the bone marrow (G), spleen (H), and blood (I) from healthy mice (n = 9) and focal TMA mice (WT: n = 4, Gsdmd−/−: n = 3). (J-L) Percentage of mature and immature neutrophils among CD45+ cells in the bone marrow (J), spleen (K), and blood (L) from healthy mice (n = 9) and focal TMA mice (WT: n = 4, Gsdmd−/−: n = 3). (M) Bone marrow cells isolated from WT and Gsdmd−/− healthy mice were incubated for 24 hours with or without granulocyte colony–stimulating factor (G-CSF; 100 ng/mL) or tumor necrosis factor alpha (TNFα; 20 ng/mL). The expression levels of CXCR2 in mature neutrophils (Ly6G+ CD101+) were quantified as mean fluorescence intensity (MFI) using flow cytometry. Data are representative of 3 independent experiments. (N) Expression levels of β2 integrin MAC-1 in bone marrow neutrophils from healthy mice (n = 5) and focal TMA mice (WT: n = 8, Gsdmd−/−: n = 7), shown as MFI quantified by flow cytometry. The data represent mean ± SD. ∗P < .05, ∗∗P < .01, and ∗∗∗P < .001 using 1-way ANOVA with Tukey post hoc test for panels B-E,G-I,N or 2-way ANOVA with Bonferroni multiple comparisons test for panels J-M.

Neutrophil recruitment and maturation are impaired in Gsdmd−/− mice with focal TMA. (A) Representative gating of flow cytometric analysis for the quantification of neutrophils (CD45+ CD11b+ Ly6G+) and monocytes (CD45+ CD11b+ Ly6C+) in blood and kidney from WT and knockout (Gsdmd−/−) mice with focal TMA (24 hours). (B-C) Percentage of neutrophils among CD45+ cells (B) and their absolute number (C) in the blood from healthy mice (n = 6) and focal TMA mice (WT: n = 8, Gsdmd−/−: n = 8). (D-E) Percentage of neutrophils among CD45+ cells (D) and their absolute number (E) in sham (n = 4) and TMA kidneys from WT (n = 12) and Gsdmd−/− (n = 11) mice. (F) Representative gating of flow cytometric analysis for the quantification of mature (CD45+ CD11b+ Ly6G+ CD101+) and immature (CD45+ CD11b+ Ly6G+ CD101) neutrophils in the bone marrow, spleen, and blood from WT and Gsdmd−/− mice with focal TMA. (G-I) Percentage of mature neutrophils among CD45+ CD11b+ Ly6G+ neutrophils in the bone marrow (G), spleen (H), and blood (I) from healthy mice (n = 9) and focal TMA mice (WT: n = 4, Gsdmd−/−: n = 3). (J-L) Percentage of mature and immature neutrophils among CD45+ cells in the bone marrow (J), spleen (K), and blood (L) from healthy mice (n = 9) and focal TMA mice (WT: n = 4, Gsdmd−/−: n = 3). (M) Bone marrow cells isolated from WT and Gsdmd−/− healthy mice were incubated for 24 hours with or without granulocyte colony–stimulating factor (G-CSF; 100 ng/mL) or tumor necrosis factor alpha (TNFα; 20 ng/mL). The expression levels of CXCR2 in mature neutrophils (Ly6G+ CD101+) were quantified as mean fluorescence intensity (MFI) using flow cytometry. Data are representative of 3 independent experiments. (N) Expression levels of β2 integrin MAC-1 in bone marrow neutrophils from healthy mice (n = 5) and focal TMA mice (WT: n = 8, Gsdmd−/−: n = 7), shown as MFI quantified by flow cytometry. The data represent mean ± SD. ∗P < .05, ∗∗P < .01, and ∗∗∗P < .001 using 1-way ANOVA with Tukey post hoc test for panels B-E,G-I,N or 2-way ANOVA with Bonferroni multiple comparisons test for panels J-M.

or Create an Account

Close Modal
Close Modal